loading

Cellectar Biosciences Inc (CLRB) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
기간 3개월 3개월 3개월 3개월 3개월
Revenues
-
- - - -
Research and Development
7.04%
7.3779
7.9365 7.3125 6.3084 6.6541
Costs And Expenses
4.35%
12.00
12.55 9.4135 8.294 8.7053
Operating Income/Loss
4.35%
-12.00
-12.55 -9.4135 -8.294 -8.7053
Nonoperating Income/Loss
290.11%
-9.5802
5.0392 -4.3189 0.0728 0.124
Income/Loss From Continuing Operations Before Tax
3.19%
-12.00
-11.63 -9.4135 -8.2212 -8.5813
Income/Loss From Continuing Operations After Tax
189.74%
-21.58
-7.4487 -13.73 -8.2212 -8.5813
Net Income/Loss
189.74%
-21.58
-7.4487 -13.73 -8.2212 -8.5813
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
3,008%
29.35
0.9443 11.31 11.26 11.26
Diluted Average Shares
3,008%
29.35
0.9443 11.31 11.26 11.26
Basic Earnings Per Share
85.00%
-0.74
-0.40 -1.21 -0.73 -0.76
Diluted Earnings Per Share
85.00%
-0.74
-0.40 -1.21 -0.73 -0.76
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$26.55
price down icon 1.28%
$196.11
price down icon 1.22%
$28.98
price down icon 9.71%
$69.58
price up icon 1.94%
$127.27
price up icon 3.16%
$538.98
price up icon 0.25%
자본화:     |  볼륨(24시간):